IA
AXSM icon

Integrity Alliance’s Axsome Therapeutics AXSM Stock Holding History

Integrity Alliance’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Sell
8,983
-602
-6% -$131K 0.07% 215
2026
Q1 		$1.62M Sell
9,585
-20
-0.2% -$3.46K 0.06% 231
2025
Q4 		$1.75M Buy
+9,605
New +$1.34M 0.06% 230

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrity Alliance's AXSM Position: Q2 2026 in Review

Integrity Alliance reduced its Axsome Therapeutics (AXSM) stake by 6.3% in Q2 2026, selling an estimated $131K and leaving 8,983 shares worth $2.2M. The position accounts for 0.07% of the portfolio, ranked #215.

Integrity Alliance first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Integrity Alliance held 8,983 shares of Axsome Therapeutics worth $2.2M as of Q2 2026.
  • Integrity Alliance sold 602 Axsome Therapeutics shares in Q2 2026, an estimated $131K.
  • Axsome Therapeutics made up 0.07% of Integrity Alliance's portfolio in Q2 2026, its #215 holding.
  • Integrity Alliance first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.